Nedocromil sodiumis amedicationconsidered as mast cell stabilizer which acts to prevent wheezing, shortness of breath, and other breathing problems caused byasthma.It is administered by aninhalerunder the brand nameTilade,and as aneye dropunder the brand nameAlocril.[1][2]The effects of nedocromil versus asthma are gradual rather than fast-acting and it is not indicated for acute respiratory distress compared to fast acting bronchodilators likealbuterolor other well-knowninhalermedications. Liquid preparations of nedocromil are available in theUKunder the nameRapitilfor use for allergic eye reactions.[3]Nedocromil sodium has been shown to be effective in alleviating symptoms ofallergic conjunctivitis.[4]
Clinical data | |
---|---|
Trade names | Alocril |
AHFS/Drugs.com | Monograph |
MedlinePlus | a601243 |
Routes of administration | Inhalationandeye drops |
ATC code | |
Legal status | |
Legal status | |
Pharmacokineticdata | |
Protein binding | 89% |
Metabolism | not metabolized |
Eliminationhalf-life | ~3.3 hours |
Excretion | excreted unchanged |
Identifiers | |
| |
CAS Number | |
PubChemCID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard(EPA) | |
ECHA InfoCard | 100.233.208 |
Chemical and physical data | |
Formula | C19H17NO7 |
Molar mass | 371.345g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Nedocromil is classified as abenzopyrone.Nedocromil acts as amast cell stabilizer,inhibits the degranulation ofmast cells,prevents release ofhistamineandtryptase,so preventing the synthesis ofprostaglandinsandleukotrienes.US Production of inhaled nedocromil ceased in April 2008 because it usedCFCsas propellant.[5]
See also
editReferences
editMedia related toNedocromilat Wikimedia Commons
- ^"ALOCRIL Product Information".Allergan. Archived fromthe originalon 8 May 2013.Retrieved17 May2013.
- ^Allen H. Dajani S (ed.)."ALOCRIL (nedocromil sodium) solution/ drops".DailyMed.U.S. National Institutes of Health.Retrieved17 May2013.
- ^"Nedocromil eye drops".Patient.info.2007-02-02.Retrieved2009-08-04.
- ^Castillo M, Scott NW, Mustafa MZ, Mustafa MS, Azuara-Blanco A (June 2015)."Topical antihistamines and mast cell stabilisers for treating seasonal and perennial allergic conjunctivitis"(PDF).The Cochrane Database of Systematic Reviews.2015(6): CD009566.doi:10.1002/14651858.CD009566.pub2.hdl:2164/6048.PMC10616535.PMID26028608.
- ^"Questions and Answers:Phase-Out of CFC Metered-Dose Inhalers Containing flunisolide, triamcinolone, metaproterenol, pirbuterol, albuterol and ipratropium in combination, cromolyn, and nedocromil".U.S. Food and Drug Administration. 13 April 2010. Archived fromthe originalon 2 February 2012.